澳大利亚主要剧院公司尽管吸引越来越多的观众，却仍然面临严重的财务困难。根据澳大利亚统计局2025年的调查，22.8%的澳大利亚人在过去12个月内参加过戏剧演出1。尽管观众热度持续，昆士兰剧院2025年观众增长5.6%、票房收入增长42%，但该机构仍录得989,000澳元的赤字1。同样，悉尼剧院公司2025年收入达到2875万澳元，却仍面临876万澳元的运营亏损1。
剧院的财务困境源于结构性的成本压力。一次11名演员制作、包含4周排练和4周演季的演出，仅演员工资最低就需154,400澳元1；《摩门经音乐剧》的澳大利亚版本制作成本更是高达1150万澳元1。1966年经济学家提出的"成本病"理论指出，剧院作为劳动密集型产业，无法像制造业那样通过技术提高生产效率，而工资、场地等成本却在持续上升1。
为缓解这一困境，一些国家已采取扶持措施。英国的戏剧税收减免计划允许符合条件的剧院公司获得接近50%的税收抵免1；澳大利亚已对符合条件的电影制作支出提供30-40%的抵扣1。
Despite growing attendance at theatrical productions in Australia, major theatre companies continue to struggle with significant financial losses. Queensland Theatre saw audience numbers rise by 5.6% and box office revenue increase by 42% in 2025, yet still recorded a deficit of A$989,000.1 Similarly, Sydney Theatre Company reported revenues of A$28.75 million in 2025 but posted an operating loss of A$8.76 million.1 According to an Australian Bureau of Statistics survey conducted in 2025, 22.8% of Australians attended theatre performances within the preceding 12 months.1
The financial difficulties facing Australia's theatre sector stem from what economists call the "cost disease" — a phenomenon first identified in 1966 by economists Baumol and Bowen, who noted that labour-intensive industries like theatre cannot increase productivity in the way manufacturing can.1 Production costs continue to climb substantially. A production featuring 11 actors with four weeks of rehearsal and a four-week performance season incurs minimum actor wages of A$154,400 alone,1 while international productions carry even higher price tags; the Australian version of The Book of Mormon required A$11.5 million in production costs.1
The United Kingdom offers precedent through its theatre tax relief scheme, which allows eligible theatre companies to claim tax credits approaching 50%.1 Australia has similarly extended tax offsets of 30-40% for qualifying film production expenditures,1 though comparable mechanisms for theatre remain limited.
评论
还没有评论，欢迎留下第一条。